# Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

> **NCT00095004** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 167 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** MK0462, rizatriptan benzoate / Duration of Treatment: 1day
- **DRUG:** Comparator: placebo / Duration of Treatment: 1 day

## Key facts

- **NCT ID:** NCT00095004
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-21
- **Primary completion:** 2005-04-01
- **Final completion:** 2005-04-04
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095004, "Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00095004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*